MoneyWorks4Me

Ajanta Pharma’s promoters offload 3.07% stake

12 Jul 2017 Evaluate

Ajanta Pharma’s promoters have sold 27 lakh equity shares or 3.07% stake in the company. Consequent to sale, promoter holding has come down from 73.78% to 70.71% stake in the company. This sale has been done to provide liquidity to the promoters and the proceeds will be utilized for personal use.

Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.

Ajanta Pharma Share Price

3560.00 19.30 (0.55%)
28-Aug-2026 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1922.35
Dr. Reddys Labs. 1174.70
Cipla 1416.80
Lupin 2171.05
Zydus Lifesciences 1174.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: